MYO logo

MYOMO INC

MYONYSE AMERICAN
🏆 #4297 by market capEarnings Nov 11US Equity
$1.25▲ $0.05 (+4.17%)
Pre-market · at close
🔔
Track MYO
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 4.2%
7d▲ 2.0%
14d▼ 3.8%
30d▼ 19.4%
ytd▲ 35.4%
1y▲ 31.0%
🏦Market Cap
$50M
Small Cap
📈Revenue Growth (YoY)
25.7%
High Growth
📊Gross Margin
68.3%
High
💵FCF Margin
-20.4%
Thin
⚖️P/S Ratio
1.1x
Cheap
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
$1.19 – $1.26
52-Week Range
$0.61 – $1.89
Volume (shares)
14,217
Avg Volume (shares)
—
Shares Outstanding
39.6M
Next Earnings
2026-11-11

Fundamentals Snapshot

Annual Revenue
$41M
Last Q Revenue
$12M
P/E Ratio
-3.5
P/S Ratio
1.1x
EPS (TTM)
$-0.34
Dividend Yield
0.00%
Dilution (1yr)
+7.6%
MYO logo

MYOMO INC

MYO
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$41M▲ +25.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
65.7%▼ −7.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$14M▲ +132.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$16M▲ +249.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
41.9M▲ +7.6% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$5M▼ −$22M YoY
StockOtter · stockotter.space

About MYOMO INC

Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100

Analyst Ratings

ⓘ
Consensus
Buy
9 analysts
Strong Buy1
Buy7
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.